Vivani Medical Inc. (VANI)
1.21
0.02 (1.68%)
At close: Jan 15, 2025, 3:59 PM
1.21
0.00%
After-hours Jan 15, 2025, 06:23 PM EST
Company Description
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need.
It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
The company is headquartered in Emeryville, California.
Vivani Medical Inc.
| Country | United States |
| IPO Date | Nov 19, 2014 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 36 |
| CEO | Adam Mendelsohn Ph.D. |
Contact Details
Address: 5858 Horton Street EmeryVille, California United States | |
| Website | https://www.vivani.com |
Stock Details
| Ticker Symbol | VANI |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001266806 |
| CUSIP Number | 92854B109 |
| ISIN Number | US92854B1098 |
| Employer ID | 00-0000000 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Adam Mendelsohn Ph.D. | Co-Founder, Chief Executive Officer & Director |
| Donald Dwyer M.B.A. | Chief Business Officer & Corporate Secretary |
| Dr. Lisa E. Porter M.D. | Chief Medical Officer |
| Truc Le M.B.A. | Chief Operations Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 03, 2025 | 4 | Filing |
| Jan 03, 2025 | 4 | Filing |
| Nov 13, 2024 | 4 | Filing |
| Nov 13, 2024 | 10-Q | Quarterly Report |
| Nov 13, 2024 | 8-K | Current Report |
| Oct 22, 2024 | 8-K | Current Report |
| Oct 03, 2024 | 4 | Filing |
| Sep 26, 2024 | 8-K | Current Report |
| Sep 23, 2024 | 8-K | Current Report |
| Sep 04, 2024 | 8-K | Current Report |